School of Medicine

 Bennett Van Houten, professor of pharmacology and chemical biology at the University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center
Bennett Van Houten and a team of researchers at UPMC Hillman Cancer Center provide the first concrete evidence for the long-held belief that sick mitochondria pollute the cells they’re supposed to be supplying with power. It's a process Van Houten calls "the Chernobyl effect."
A healthcare professional using a tablet
It can take 100 clicks for a doctor to order the right test and check a patient’s health history using a typical electronic health record. Yalini Senathirajah has designed a program that could reduce that digital burden and improve patient care.
Headshot of Ruslan Medzhitov
Ruslan Medzhitov, a Yale University researcher who transformed the understanding of how the immune system detects infections, which paved the way for therapies for a wide range of diseases, received the 2019 Dickson Prize in Medicine, the University of Pittsburgh School of Medicine’s highest honor.
Garrett Coyan at the 2019 Pitt Innovation Challenge
To address the critical need for long-lasting heart valve replacements, a team of Pitt researchers created a mesh that harnesses the body’s own healing power.
Dr. Bernard Fisher
Dr. Bernard Fisher, Distinguished Service Professor at the University of Pittsburgh School of Medicine and a true pioneer in the field of breast cancer research, died on Wednesday evening at the age of 101.
The CyteSolutions Lens
Dry eye affects millions of Americans a year, but available treatments can require continuous application. A Pitt bioengineering student and an eye doctor with the School of Medicine make up part of a team that invented a more efficient and sustained treatment delivery method.
The HIV Detective is a solution being developed for early, rapid diagnosis of HIV. The handheld testing platform would allow health care workers to gather a few drops of blood onto a sensor and provide results in one minute instead of the 24 hours currently required. This leap forward in testing is possible due to another recently developed Pitt technology — a THC breath test.
J.T. Borofka
Pitt's Michael Palladino is the only researcher actively pursuing a cure for triosephosphate isomerase deficiency. Eleven-month old J.T. Borofka has this severe metabolic disorder, which is characterized by a shortage of red blood cells (anemia), neurological problems, infections and muscle weakness that can affect breathing and heart function. It is so rare that only eight known cases exist around the world — four of which have been identified in the United States.